Forward Pharma's IPO

Forward Pharma raised a round of funding on October 15, 2014. Investors include Public.

Forward Pharma is a privately held biotechnology company focused on the immunomodulatory compound dimethyl fumarate and derivatives, for applications as a pharmaceutical drug product to treat immune d…

Articles about Forward Pharma's IPO: